Guang-feng Zhou
State Key Laboratory Of Genetic Evolution & Animal Models, Key Laboratory Of Bioactive Peptides Of Yunnan Province, KIZ CUHK Joint Laboratory Of Bioresources And Molecular Research In Common Diseases
Kunming, 650223, China
Kunming, 650223, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Anti-zika virus agents and viral RdRp enzymatic inhibitors of derivatives of 5-membered pyrrolo[3,4-b]indol-3(4H)-one and 6-membered pyridazino[4,5-b]indol-4(5H)-one.
Journal: European journal of medicinal chemistry
Published: December 15, 2025
Discovery of 2-aryl-1H-pyrazole-S-DACO analogs as novel inhibitors targeting the DENV NS5 protein.
Journal: Bioorganic chemistry
Published: April 28, 2025
Corrigendum to "Discovery of ZFD-10 of a pyridazino[4,5-b]indol-4(5H)-one derivative as an anti-ZIKV agent and a ZIKV NS5 RdRp inhibitor" [Antivir. Res. 214 (2023) 105607].
Journal: Antiviral research
Published: October 29, 2024
Inhibiting cardiac autophagy suppresses Zika virus replication.
Journal: Journal of medical virology
Published: September 16, 2022
Identification of 6ω-cyclohexyl-2-(phenylamino carbonylmethylthio)pyrimidin-4(3H)-ones targeting the ZIKV NS5 RNA dependent RNA polymerase.
Journal: Frontiers in chemistry
Published: August 03, 2022
Antiviral effects of the fused tricyclic derivatives of indoline and imidazolidinone on ZIKV infection and RdRp activities of ZIKV and DENV.
Journal: Virus research
Published: July 25, 2022
Discovery of dehydroandrographolide derivatives with C19 hindered ether as potent anti-ZIKV agents with inhibitory activities to MTase of ZIKV NS5.
Journal: European journal of medicinal chemistry
Published: June 29, 2022
Design, synthesis, discovery and SAR of the fused tricyclic derivatives of indoline and imidazolidinone against DENV replication and infection.
Journal: Bioorganic chemistry
Published: October 16, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026